Influence of socio-economic status on functional recovery after ARDS caused by SARS-CoV-2: the multicentre, observational RECOVIDS study

被引:3
|
作者
Declercq, Pierre-Louis [1 ]
Fournel, Isabelle [2 ,3 ]
Demeyere, Matthieu [4 ]
Berraies, Anissa [5 ]
Ksiazek, Elea [2 ,3 ]
Nyunga, Martine [6 ]
Daubin, Cedric [7 ]
Ampere, Alexandre [8 ]
Sauneuf, Bertrand [9 ]
Badie, Julio [10 ]
Delbove, Agathe [11 ]
Nseir, Saad [12 ,13 ]
Artaud-Macari, Elise [14 ]
Bironneau, Vanessa [15 ,16 ]
Ramakers, Michel [17 ]
Maizel, Julien [18 ]
Miailhe, Arnaud-Felix [19 ]
Lacombe, Beatrice [20 ]
Delberghe, Nicolas [21 ]
Oulehri, Walid [22 ]
Georges, Hugues [23 ]
Tchenio, Xavier [24 ]
Clarot, Caroline [25 ]
Redureau, Elise [26 ]
Bourdin, Gael [27 ]
Federici, Laura [28 ]
Adda, Melanie [29 ]
Schnell, David [30 ]
Bousta, Mehdi [31 ]
Salmon-Gandonniere, Charlotte [32 ]
Vanderlinden, Thierry [33 ]
Plantefeve, Gaetan [34 ]
Delacour, David [35 ]
Delpierre, Cyrille [36 ]
Le Bouar, Gurvan [37 ]
Sedillot, Nicholas
Beduneau, Gaetan [38 ]
Riviere, Antoine [39 ]
Meunier-Beillard, Nicolas [2 ]
Gelinotte, Stephanie [1 ]
Rigaud, Jean-Philippe [1 ,40 ]
Labruyere, Marie [41 ,42 ,43 ,44 ]
Georges, Marjolaine [45 ,46 ]
Binquet, Christine [2 ,3 ]
Quenot, Jean-Pierre [41 ,42 ,43 ,44 ]
机构
[1] CH Dieppe, Serv Med Intens Reanimat, Dieppe, France
[2] CHU Dijon, Ctr Invest Clin, Dijon, France
[3] INSERM, CIC 1432, Module Epidemiol Clin, Dijon, France
[4] CHU Rouen, Serv Radiol, F-76000 Rouen, France
[5] CH Chartres, Serv Pneumol, Chartres, France
[6] CH Roubaix, Serv Med Intens Reanimat, Roubaix, France
[7] CHU Caen Normandie, Dept Med Intens Care, Caen, France
[8] CH Bethune, Serv Pneumol, Bethune, France
[9] CH Publ Cotentin, Serv Med Intens Reanimat, Cherbourg En Cotentin, France
[10] Hop Nord Franche Comte, Serv Med Intens Reanimat, Trevenans, France
[11] CHBA Vannes, Serv Reanimat Polyvalente, Vannes, France
[12] CHRU Roger Salengro, Serv Med Intens Reanimat, Lille, France
[13] Univ Lille, UGSF Unite Glycobiol Struct & Fonct, CNRS, Inserm U1285,UMR 8576, Lille, France
[14] Univ Normandie, Dept Pneumol, Thorac Oncol & Resp Intens Care Unit, UNIROUEN,EA3830,CHU Rouen, Rouen, France
[15] CHU Poitiers, Serv Pneumol, Poitiers, France
[16] Univ Poitiers, INSERM CIC 1402, ALIVES Res Grp, Poitiers, France
[17] Ctr Hosp Mem St Lo, Serv Med Intens Reanimat, St Lo, France
[18] CHU Amiens, Serv Med Intens Reanimat, Amiens, France
[19] CHU Nantes, Serv Med Intens Reanimat, Nantes, France
[20] Grp Hosp Bretagne Sud, Serv Reanimat Polyvalente, Lorient, France
[21] CHES Evreux, Serv Pneumol, Evreux, France
[22] CHRU Strasbourg, Serv Reanimat Chirurgicale, Strasbourg, France
[23] CH Tourcoing, Serv Med Intens Reanimat, Tourcoing, France
[24] Ctr Hosp Fleyriat, Serv Reanimat Polyvalente, Bourg En Bresse, France
[25] CH Abbeville, Serv Pneumol, Abbeville, France
[26] CHD Vendee, Serv Pneumol, La Roche Sur Yon, France
[27] CH St Joseph St Luc, Serv Reanimat Polyvalente, Lyon, France
[28] Hop Louis Mourier, AP HP, Serv Med Intens Reanimat, Colombes, France
[29] Hop Nord Marseille, Hop Marseille, Serv Med Intens Reanimat, Marseille, France
[30] CH Angouleme, Serv Reanimat Polyvalente & USC, Angouleme, France
[31] Grp Hosp Havre, Serv Reanimat Med Chirug, Le Havre, France
[32] CHRU Tours, Serv Med Intens Reanimat, Tours, France
[33] Lille Catholic Univ, St Philibert Hosp, Intens Care Unit, ETHICS EA 7446, Lille, France
[34] CH Argenteuil, Serv Med Intens Reanimat, Argenteuil, France
[35] Clin Cedre, Serv Radiol, Bois Guillaume, France
[36] Univ Toulouse, CERPOP, Inserm, Toulouse, France
[37] CHES Evreux, Serv Med Intens Reanimat, Evreux, France
[38] Normandie Univ, Dept Med Intens Care, UNIROUEN, UR3830,CHU Rouen, F-76000 Rouen, France
[39] CH Abbeville, Serv Reanimat Polyvalente, Abbeville, France
[40] CHU Caen, Espace Reflex Eth Normandie, Caen, France
[41] Burgundy Univ Hosp, Dept Intens Care, 14 Rue Paul Gaffarel,BP 77908, F-21079 Dijon, France
[42] Univ Burgundy, INSERM Res Ctr LNC, Lipness Team, UMR1231, Dijon, France
[43] Univ Burgundy, LabEx LipSTIC, Dijon, France
[44] Univ Burgundy, INSERM CIC 1432, Clin Epidemiol, Dijon, France
[45] Univ Hosp, Dept Pulm Med, Dijon, France
[46] Univ Hosp, Intens Care Unit, Dijon, France
关键词
ARDS; COVID-19; Socio-economic; Deprivation; Respiratory sequelae; THORACIC SOCIETY; LUNG-FUNCTION; COVID-19; HEALTH; DEPRIVATION; SPIROMETRY; INDEX; RISK;
D O I
10.1007/s00134-023-07180-y
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purpose: Survivors after acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19) are at high risk of developing respiratory sequelae and functional impairment. The healthcare crisis caused by the pandemic hit socially disadvantaged populations. We aimed to evaluate the influence of socio-economic status on respiratory sequelae after COVID-19 ARDS. Methods: We carried out a prospective multicenter study in 30 French intensive care units (ICUs), where ARDS survivors were pre-enrolled if they fulfilled the Berlin ARDS criteria. For patients receiving high flow oxygen therapy, a flow >= 50 l/min and an FiO(2) >= 50% were required for enrollment. Socio- economic deprivation was defined by an EPICES (Evaluation de la Precarite et des Inegalites de sante dans les Centres d'Examens de Sante - Evaluation of Deprivation and Inequalities in Health Examination Centres) score >= 30.17 and patients were included if they performed the 6-month evaluation. The primary outcome was respiratory sequelae 6 months after ICU discharge, defined by at least one of the following criteria: forced vital capacity < 80% of theoretical value, diffusing capacity of the lung for carbon monoxide < 80% of theoretical value, oxygen desaturation during a 6-min walk test and fibrotic-like findings on chest computed tomography. Results: Among 401 analyzable patients, 160 (40%) were socio- economically deprived and 241 (60%) non-deprived; 319 (80%) patients had respiratory sequelae 6 months after ICU discharge (81% vs 78%, deprived vs non-deprived, respectively). No significant effect of socio-economic status was identified on lung sequelae (odds ratio (OR), 1.19 [95% confidence interval (CI), 0.72-1.97]), even after adjustment for age, sex, most invasive respiratory support, obesity, most severe P/F ratio (adjusted OR, 1.02 [95% CI 0.57-1.83]). Conclusions: In COVID-19 ARDS survivors, socio-economic status had no significant influence on respiratory sequelae 6 months after ICU discharge.
引用
收藏
页码:1168 / 1180
页数:13
相关论文
共 50 条
  • [31] Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study
    Merckx, Joanna
    Cooke, Suzette
    El Tal, Tala
    Bitnun, Ari
    Morris, Shaun K.
    Yeh, E. Ann
    Yea, Carmen
    Gill, Peter
    Papenburg, Jesse
    Lefebvre, Marie-Astrid
    Scuccimarri, Rosie
    Ulloa-Gutierrez, Rolando
    Brenes-Chacon, Helena
    Yock-Corrales, Adriana
    Ivankovich-Escoto, Gabriela
    Soriano-Fallas, Alejandra
    Hernandez-de Mezerville, Marcela
    Dewan, Tammie
    Restivo, Lea
    Nateghian, Alireza
    Aski, Behzad Haghighi
    Manafi, Ali
    Dwilow, Rachel
    Bullard, Jared
    Lopez, Alison
    Sadarangani, Manish
    Roberts, Ashley
    Barton, Michelle
    Petel, Dara
    Le Saux, Nicole
    Bowes, Jennifer
    Purewal, Rupeena
    Lautermilch, Janell
    Tehseen, Sarah
    Bayliss, Ann
    Wong, Jacqueline K.
    Leifso, Kirk
    Foo, Cheryl
    Robinson, Joan
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (14) : E513 - E523
  • [32] Protocol for a prospective, observational, hospital-based multicentre study of nosocomial SARS-CoV-2 transmission: NOSO-COR Project
    Saadatian-Elahi, Mitra
    Picot, Valentina
    Henaff, Laetitia
    Pradel, Florence K.
    Escuret, Vanessa
    Dananche, Cedric
    Elias, Christelle
    Endtz, Hubert P.
    Vanhems, Philippe
    BMJ OPEN, 2020, 10 (10):
  • [33] SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection
    Zhan, Yan
    Zhu, Yufang
    Wang, Shanshan
    Jia, Shijun
    Gao, Yunling
    Lu, Yingying
    Zhou, Caili
    Liang, Ran
    Sun, Dingwen
    Wang, Xiaobo
    Hou, Zhibing
    Hu, Qiaoqiao
    Du, Peng
    Yu, Hao
    Liu, Chang
    Cui, Miao
    Tong, Gangling
    Zheng, Zhihua
    Xu, Yunsheng
    Zhu, Linyu
    Cheng, Jin
    Wu, Feng
    Zheng, Yulan
    Liu, Peijun
    Hong, Peng
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [34] SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection
    Yan Zhan
    Yufang Zhu
    Shanshan Wang
    Shijun Jia
    Yunling Gao
    Yingying Lu
    Caili Zhou
    Ran Liang
    Dingwen Sun
    Xiaobo Wang
    Zhibing Hou
    Qiaoqiao Hu
    Peng Du
    Hao Yu
    Chang Liu
    Miao Cui
    Gangling Tong
    Zhihua Zheng
    Yunsheng Xu
    Linyu Zhu
    Jin Cheng
    Feng Wu
    Yulan Zheng
    Peijun Liu
    Peng Hong
    Signal Transduction and Targeted Therapy, 6
  • [35] Spatial and temporal epidemiology of SARS-CoV-2 virus lineages in Teesside , UK, in 2020: effects of socio-economic deprivation, weather, and lockdown on lineage dynamics
    Moss, E. D.
    Rushton, S. P.
    Baker, P.
    Bashton, M.
    Crown, M. R.
    dos Santos, R. N.
    Nelson, A.
    O'Brien, S. J.
    Richards, Z.
    Sanderson, R. A.
    Yew, W. C.
    Young, G. R.
    Mccann, C. M.
    Smith, D. L.
    PEER COMMUNITY JOURNAL, 2024, 4
  • [36] The impacts of the novel SARS-CoV-2 outbreak on surgical oncology - A letter to the editor on "The socio-economic implications of the coronavirus and COVID-19 pandemic: A review"
    Shubber, Nour
    Sheppard, Jack
    Alradhawi, Mohammad
    Ali, Yousif
    INTERNATIONAL JOURNAL OF SURGERY, 2020, 79 : 109 - 110
  • [37] Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2: protocol for an observational cohort study (LongCOVID-study)
    Mutubuki, Elizabeth N.
    van der Maaden, Tessa
    Leung, Ka Yin
    Wong, Albert
    Tulen, Anna D.
    de Bruijn, Simeon
    Haverman, Lotte
    Knoop, Hans
    Franz, Eelco
    van Hoek, Albert Jan
    van den Wijngaard, Cees C.
    BMJ OPEN, 2022, 12 (07):
  • [38] Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study
    Zhu, Xianming
    Gebo, Kelly A.
    Abraham, Alison G.
    Habtehyimer, Feben
    Patel, Eshan U.
    Laeyendecker, Oliver
    Gniadek, Thomas J.
    Fernandez, Reinaldo E.
    Baker, Owen R.
    Ram, Malathi
    Cachay, Edward R.
    Currier, Judith S.
    Fukuta, Yuriko
    Gerber, Jonathan M.
    Heath, Sonya L.
    Meisenberg, Barry
    Huaman, Moises A.
    Levine, Adam C.
    Shenoy, Aarthi
    Anjan, Shweta
    Blair, Janis E.
    Cruser, Daniel
    Forthal, Donald N.
    Hammitt, Laura L.
    Kassaye, Seble
    Mosnaim, Giselle S.
    Patel, Bela
    Paxton, James H.
    Raval, Jay S.
    Sutcliffe, Catherine G.
    Abinante, Matthew
    Broderick, Patrick
    Cluzet, Valerie
    Cordisco, Marie Elena
    Greenblatt, Benjamin
    Petrini, Joann
    Rausch, William
    Shade, David
    Lane, Karen
    Gawad, Amy L.
    Klein, Sabra L.
    Pekosz, Andrew
    Shoham, Shmuel
    Casadevall, Arturo
    Bloch, Evan M.
    Hanley, Daniel
    Sullivan, David J.
    Tobian, Aaron A. R.
    LANCET MICROBE, 2023, 4 (09): : E692 - E703
  • [39] Risk of SARS-CoV-2 reinfection 18 months after first infection: population-level observational study
    Flacco, M. E.
    Martellucci, C. Acuti
    Soldato, G.
    Di Martino, G.
    Carota, R.
    Caponetti, A.
    Manzoli, L.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32
  • [40] Evaluation of the socio-sanitary and emotional impact caused by SARS-CoV-2 in a Spanish cohort of cancer patients after the second pandemic wave
    Herrero Rivera, D.
    Lopez Martin, S.
    Manzano Moro, D.
    Esteban Herrera, B.
    Garcia Sanchez, L.
    Fiorini Talavera, A. B.
    de la Cruz Palomero, V.
    Gassent Blesa, J. M.
    Soriano Segura, M.
    Reche Santos, E.
    Cornide Santos, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1156 - S1156